Drug Interaction Between Tramadol and Methocarbamol

Primary Concern: CNS Depression

The American College of Emergency Physicians and other medical societies warn that opioids like tramadol must be used cautiously or avoided when combined with other CNS depressants, including skeletal muscle relaxants like methocarbamol, as this combination increases risks of respiratory depression, excessive sedation, and adverse cardiovascular effects outside of highly monitored clinical settings 1
Methocarbamol acts as a centrally acting skeletal muscle relaxant and sedative, causing drowsiness, dizziness, bradycardia, and hypotension as adverse effects, according to the Mayo Clinic 2
The Society for Perioperative Assessment and Quality Improvement specifically recommends holding methocarbamol on the day of surgical procedures to avoid these compounded effects 2

Tramadol has dual mechanisms of action (weak mu-opioid agonist plus serotonin and norepinephrine reuptake inhibition), which creates a distinct adverse effect profile compared to traditional opioids, as noted by the National Comprehensive Cancer Network 3
Seizure risk is elevated with tramadol, particularly at doses exceeding 400 mg daily, and this risk may be further increased when combined with other CNS-active medications, according to the World Journal of Emergency Surgery and the British Journal of Cancer 1, 4

The World Journal of Emergency Surgery recommends considering alternative muscle relaxants or analgesics first before combining tramadol and methocarbamol, and if combination cannot be avoided, using the lowest effective doses of both medications and implementing close monitoring for respiratory depression, excessive sedation, and cardiovascular instability 1, 2
The Journal of the National Comprehensive Cancer Network suggests adjusting tramadol dosing to maximum 400 mg/day for immediate-release formulations in adults with normal hepatic and renal function, and reducing tramadol doses further for elderly patients and those with hepatic or renal dysfunction 3

Elderly patients are particularly vulnerable to the combined CNS depressant effects and face increased risk of morphine accumulation, over-sedation, and respiratory depression when using opioids, as warned by the World Journal of Emergency Surgery 1
Patients with hepatic or renal disease have significantly impaired elimination of methocarbamol and require dose adjustments, according to the Mayo Clinic 2
Methocarbamol should not be used in patients with myasthenia gravis as it interferes with pyridostigmine bromide effects, as noted by the Mayo Clinic 2

The World Journal of Emergency Surgery advises against assuming this combination is safe simply because both are commonly prescribed medications—the additive CNS depression can be clinically significant 1
The British Journal of Cancer and the Journal of the National Comprehensive Cancer Network warn against combining tramadol with multiple CNS depressants simultaneously, as this exponentially increases risk, and against overlooking tramadol's serotonergic properties, which increase serotonin syndrome risk when used with SSRIs, TCAs, or MAOIs 3, 4